Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Nightingale

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
Pharmacotherapy|March 24, 2000
Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristicsC H Nightingale
Nursing Forum|January 1, 1970
The effect on nursing of the changing role of the pharmacistC H Nightingale
Pharmacotherapy|September 1, 1996
Treating allergic rhinitis with second-generation antihistaminesC H Nightingale
The Pediatric Infectious Disease Journal|April 1, 1997
Pharmacokinetics and pharmacodynamics of newer macrolidesC H Nightingale
International Journal of Antimicrobial Agents|July 1, 1994
Implications of fleroxacin's pharmacokinetic profileC H Nightingale
Hospital Formulary|September 1, 1994
How to develop critical paths and prepare for other formulary management changesS McCaffrey, C H Nightingale
Pharmacotherapy|January 1, 1991
Antimicrobials and therapeutic decision making: an historical perspectiveR Quintiliani, C H Nightingale
Journal of Pharmaceutical Sciences|May 1, 1973
Reliable and simple method of intravenous injection into the laboratory ratC H Nightingale, M Mouravieff
Pharmacology & Toxicology|November 1, 1993
Biphenylacetate, but not theophylline, lethally interacts with ciprofloxacin in miceJ Zhi, C H Nightingale
Annals of Internal Medicine|November 1, 1978
CefazolinR Quintiliani, C H Nightingale
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
Pharmacotherapy|March 24, 2000
Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristicsC H Nightingale
Nursing Forum|January 1, 1970
The effect on nursing of the changing role of the pharmacistC H Nightingale
Pharmacotherapy|September 1, 1996
Treating allergic rhinitis with second-generation antihistaminesC H Nightingale
The Pediatric Infectious Disease Journal|April 1, 1997
Pharmacokinetics and pharmacodynamics of newer macrolidesC H Nightingale
International Journal of Antimicrobial Agents|July 1, 1994
Implications of fleroxacin's pharmacokinetic profileC H Nightingale
Hospital Formulary|September 1, 1994
How to develop critical paths and prepare for other formulary management changesS McCaffrey, C H Nightingale
Pharmacotherapy|January 1, 1991
Antimicrobials and therapeutic decision making: an historical perspectiveR Quintiliani, C H Nightingale
Journal of Pharmaceutical Sciences|May 1, 1973
Reliable and simple method of intravenous injection into the laboratory ratC H Nightingale, M Mouravieff
Pharmacology & Toxicology|November 1, 1993
Biphenylacetate, but not theophylline, lethally interacts with ciprofloxacin in miceJ Zhi, C H Nightingale
Annals of Internal Medicine|November 1, 1978
CefazolinR Quintiliani, C H Nightingale
Pageof 28